These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10513728)

  • 21. Generics: is there a choice?
    Ryan AJ
    Postgrad Med; 1978 May; 63(5):20-1. PubMed ID: 643766
    [No Abstract]   [Full Text] [Related]  

  • 22. Major events during the generic drug investigations.
    Am Pharm; 1990 Jul; NS30(7):38-9. PubMed ID: 2363392
    [No Abstract]   [Full Text] [Related]  

  • 23. Genesis of generic drugs.
    Calesnick B; Kreider LA; Dinan A
    Pa Med; 1986 Dec; 89(12):32, 34, 36. PubMed ID: 3808720
    [No Abstract]   [Full Text] [Related]  

  • 24. Multinational medicines--ensuring drug quality in an era of global manufacturing.
    Okie S
    N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of FDA and EMA drug approval: implications for drug development and cost of care.
    Howie LJ; Hirsch BR; Abernethy AP
    Oncology (Williston Park); 2013 Dec; 27(12):1195, 1198-1200, 1202 passim. PubMed ID: 24624536
    [No Abstract]   [Full Text] [Related]  

  • 26. Descriptive tools and analysis.
    Capellà D
    WHO Reg Publ Eur Ser; 1993; 45():55-78. PubMed ID: 8442851
    [No Abstract]   [Full Text] [Related]  

  • 27. Generic drugs versus brand names: switching could save money. Generic drugs have to go through the same FDA approvals as brand names, so they have the same quality.
    Harv Womens Health Watch; 2013 Jul; 20(11):3. PubMed ID: 24818274
    [No Abstract]   [Full Text] [Related]  

  • 28. Doctors are pivotal to prescription struggle.
    Chapman S
    Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
    [No Abstract]   [Full Text] [Related]  

  • 29. Generic bioequivalence: a scientific consensus needed.
    Am Fam Physician; 1987 Feb; 35(2):91, 95. PubMed ID: 3812175
    [No Abstract]   [Full Text] [Related]  

  • 30. Generic drug substitution revisited.
    Strom BL
    N Engl J Med; 1987 Jun; 316(23):1456-62. PubMed ID: 3553952
    [No Abstract]   [Full Text] [Related]  

  • 31. 150 years of pharmacovigilance.
    Routledge P
    Lancet; 1998 Apr; 351(9110):1200-1. PubMed ID: 9643710
    [No Abstract]   [Full Text] [Related]  

  • 32. Making "me-too" drugs benefit the public.
    Nusbaum NJ
    Am J Med Qual; 2002; 17(6):215-7. PubMed ID: 12487336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striving for standards in bioequivalence assessment: a review.
    Schulz HU; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):293-8. PubMed ID: 1743802
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs on the market.
    JAMA; 1970 Feb; 211(7):1177. PubMed ID: 5466970
    [No Abstract]   [Full Text] [Related]  

  • 35. Paediatric drug policy in Australia.
    Sinha YK; Craig JC; Brien JA
    J Paediatr Child Health; 2015 Mar; 51(3):259-62. PubMed ID: 24909989
    [No Abstract]   [Full Text] [Related]  

  • 36. Who really assures prescription drug quality?
    J Indiana State Med Assoc; 1979 Mar; 72(3):164. PubMed ID: 422862
    [No Abstract]   [Full Text] [Related]  

  • 37. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

  • 38. Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents?
    Antman EM; Ferguson JJ
    Circulation; 2003 Nov; 108(21):2604-7. PubMed ID: 14638523
    [No Abstract]   [Full Text] [Related]  

  • 39. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefits and liabilities of generic prescribing.
    Lee AM
    W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.